MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/mt.2014.84

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2014

Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.

Tsai Li-Kai, Chen Chien-Lin, Ting Chen-Hung, Lin-Chao Sue, Hwu Wuh-Liang, Dodge James C, Passini Marco A, Cheng Seng H

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Spinal muscular atrophy is a progressive motor neuron disease caused by a deficiency of survival motor neuron. In this study, we evaluated the efficacy of intravenous administration of a recombinant adeno-associated virus (AAV1) vector encoding human insulin-like growth factor-1 (IGF-1) in a severe mouse model of spinal muscular atrophy. Measurable quantities of human IGF-1 transcripts and protein were detected in the liver (up to 3 months postinjection) and in the serum indicating that IGF-1 was secreted from the liver into systemic circulation. Spinal muscular atrophy mice administered AAV1-IGF-1 on postnatal day 1 exhibited a lower extent of motor neuron degeneration, cardiac and muscle atrophy as well as a greater extent of innervation at the neuromuscular junctions compared to untreated controls at day 8 posttreatment. Importantly, treatment with AAV1-IGF-1 prolonged the animals' lifespan, increased their body weights and improved their motor coordination. Quantitative polymerase chain reaction and western blot analyses showed that AAV1-mediated expression of IGF-1 led to an increase in survival motor neuron transcript and protein levels in the spinal cord, brain, muscles, and heart. These data indicate that systemically delivered AAV1-IGF-1 can correct several of the biochemical and behavioral deficits in spinal muscular atrophy mice through increasing tissue levels of survival motor neuron.

Для цитирования: Tsai Li-Kai, Chen Chien-Lin, Ting Chen-Hung, Lin-Chao Sue, Hwu Wuh-Liang, Dodge James C, Passini Marco A, Cheng Seng H. Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.. Molecular therapy : the journal of the American Society of Gene Therapy. 2014. DOI: 10.1038/mt.2014.84.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.